Physician profile
Dane H Dougherty
NPI 1518251370
$2,208.77
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,008 · 2020: $52.28 · 2021: $13.13 · 2022: $13.04 · 2023: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $246.48 | 2019-2020 | |
| Lilly USA, LLC | $232.85 | 2019 | |
| Celgene Corporation | $229.85 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $227.05 | 2019 | |
| Horizon Therapeutics Plc | $199.45 | 2019-2023 | Krystexxa |
| Abbvie INC. | $193.60 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $174.93 | 2019 | |
| Amgen INC. | $117.02 | 2019 | |
| Ucb, INC. | $73.29 | 2019 | |
| Alexion Pharmaceuticals, INC. | $54.91 | 2019 | |
| Pacira Therapeutics, INC. | $50.78 | 2019 | |
| Braintree Laboratories, INC. | $50.52 | 2019 | |
| Pfizer INC. | $50.21 | 2019-2021 | |
| Janssen Biotech, INC. | $49.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $44.89 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $36.26 | 2019 | |
| Mallinckrodt Enterprises LLC | $35.77 | 2019 | |
| Shionogi INC | $32.21 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.86 | 2019 | |
| Merck Sharp & Dohme LLC | $28.09 | 2019 | |
| Sobi, INC | $21.39 | 2019 | |
| Radius Health, INC. | $16.47 | 2020 | |
| Glaxosmithkline, LLC. | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.